A Study to Evaluate the Safety and Tolerability of Prophylactic Emicizumab in Hemophilia A Patients With Inhibitors
Clinical trial NCT03191799 · COMPLETED
Trial details
- NCT number
- NCT03191799
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-05
- Primary completion
- 2020-11-19
- Enrollment
- 195
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.